Press release
Brain Cancer Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring Leading Companies: Y-mAbs Therapeut
Brain Cancer Market Report 2034
DelveInsight's "Brain Cancer Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of brain cancer, covering both historical and projected epidemiological trends, as well as current and future market dynamics across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Brain Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Brain Cancer Market Forecast [https://www.delveinsight.com/report-store/brain-cancer-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Some of the key facts of the Brain Cancer Market Report:
The Brain Cancer market is projected to experience significant growth with a notable CAGR over the study period (2020-2034).
In 2023, the United States held the largest market share for brain cancer among the seven major markets (7MM). Within the EU4 and the UK, Italy is expected to generate the highest revenue share by 2034, followed by Germany. In terms of incident cases, the U.S. accounted for over 38% of total cases in the 7MM in 2023.
Regarding gender distribution, males were more frequently affected, representing approximately 60% of cases, while females accounted for around 40% in the U.S. High-grade brain tumors (Grades III and IV) were more common than low-grade tumors, comprising nearly 70% of cases. Brain tumors were most prevalent among individuals aged 40-64, followed by those 65 and older. In 2023, the U.S. reported roughly 23,000 new cases of primary brain tumors, with numbers expected to increase over the forecast period.
Several notable developments occurred in recent years:
*
December 2024: Kazia Therapeutics' stock fell 26% to $2.28 after the FDA indicated it may only grant standard approval for paxalisib, a glioblastoma treatment, rather than accelerated approval. Earlier in the year, the stock had already dropped 48%, despite paxalisib showing improved overall survival in a July trial.
*
April 2024: The US FDA granted accelerated approval to Day One Biopharmaceuticals' OJEMDA (tovorafenib) for patients aged 6 months and older with certain relapsed or refractory pediatric low-grade glioma.
*
April 2024: TME Pharma received Fast Track Designation from the FDA for NOX-A12 (olaptesed pegol), a CXCL12 inhibitor, in combination with radiotherapy and bevacizumab for glioblastoma.
*
February 2024: Servier announced FDA acceptance and priority review of the NDA for vorasidenib, which could become the first targeted therapy for patients with IDH-mutant gliomas. The PDUFA date is set for August 20, 2024.
Key Companies in the brain cancer market include Y-mAbs Therapeutics Inc., Shimadzu Corporation, Bristol-Myers Squibb, Bayer AG, AstraZeneca plc, Johnson & Johnson Inc., Merck & Co., Pfizer Inc., F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, among others.
Prominent Therapies include AVASTIN (bevacizumab), TEMODAR/TEMODAL, Vorasidenib, Paxalisib, and others.
The brain cancer market is expected to expand substantially due to rising disease prevalence, increased awareness, and the introduction of multiple-stage pipeline therapies, which are likely to transform the market landscape over the coming years.
Brain Cancer Overview
A brain tumor, also known as an intracranial tumor, is an abnormal growth occurring within the brain, spinal cord, or surrounding protective tissues. These tumors are generally classified as primary or metastatic. Primary tumors are further categorized as low-grade or high-grade. Low-grade tumors usually grow slowly but can progress to high-grade, which are more aggressive. Secondary brain tumors, or brain metastases, are more common in adults than primary tumors.
Brain tumors are often undetected until symptoms appear. Diagnosis usually starts with magnetic resonance imaging (MRI). If a tumor is found, a biopsy or surgery is performed to determine the tumor type by analyzing tissue samples. Blood tests may assist in diagnosing certain tumor types, such as those in the pituitary gland, pineal region, or germ cell tumors. Advanced imaging techniques, including CT scans and MRI, help locate the tumor, while specialized MRI sequences assist surgeons in planning safe removal near critical brain structures. Intraoperative MRI is also employed during surgery to guide biopsies and tumor excision.
Treatment options for brain tumors include surgery, radiation therapy, chemotherapy, and targeted therapy, with the approach depending on tumor size, type, grade, location, whether it has spread, potential side effects, and the patient's overall health. Low-grade tumors may be treated with surgery alone if fully removable; residual tumor tissue may require radiation or chemotherapy. For high-grade tumors, the standard treatment sequence usually involves surgery followed by radiation therapy and chemotherapy.
Get a Free sample for the Brain Cancer Market Forecast [https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr], Size & Share Analysis Report
Brain Cancer Epidemiology
The epidemiology section offers a detailed overview of historical, current, and projected trends in the seven major markets (7MM) from 2020 to 2034. It examines the factors driving both present and future trends by analyzing multiple studies and insights from key opinion leaders. Additionally, the section provides an in-depth assessment of the diagnosed patient population and highlights anticipated epidemiological developments over the forecast period.
Brain Cancer Epidemiology Segmentation:
The Brain Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Diagnosed Prevalence of Brain Cancer in Adults
*
Diagnosed Prevalence of Brain Cancer in Pediatrics
*
Diagnosed Prevalence of Brain Cancer by Types
*
Diagnosed Prevalence of Brain Cancer by Location
*
Diagnosed Prevalence of Brain Cancer by Severity
Download the report to understand which factors are driving Brain Cancer epidemiology trends @ Brain Cancer Epidemiology Forecast [https://www.delveinsight.com/report-store/brain-cancer-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Brain Cancer Marketed Drugs
*
AVASTIN (bevacizumab): Genentech
*
TEMODAR/TEMODAL: Merck
Brain Cancer Emerging Drugs
*
Vorasidenib: Servier
*
Paxalisib: Kazia Therapeutics
Brain Cancer Therapies: AVASTIN (bevacizumab), TEMODAR/TEMODAL, Vorasidenib, Paxalisib, and others
Brain Cancer Key Companies: Y-mAbs Therapeutics Inc., Shimadzu Corporation, Bristol-Myers Squibb, Bayer AG, AstraZeneca plc, Johnson & Johnson Inc., Merck & Co., Pfizer Inc., F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, and others
Discover more about therapies set to grab major Brain Cancer market share @ Brain Cancer Treatment Landscape [https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Brain Cancer Market Outlook
Treatment for brain cancer generally involves a multimodal approach, including surgery, chemotherapy, radiation, or stereotactic radiosurgery, often followed by additional adjuvant therapies such as chemotherapy or radiation. Palliative care may also involve these modalities to manage symptoms.
An emerging area of treatment is immunotherapy, which seeks to activate the patient's immune system to fight and prevent tumor growth. Often described as "vaccine" therapy, this strategy triggers an immune response targeted specifically at the tumor. Immunotherapy approaches may include checkpoint inhibitors and cancer vaccines that use tumor-specific antigens. Ongoing research continues to investigate the potential of immunotherapy, along with other innovative strategies such as gene therapies and oncolytic virus treatments (utilizing viruses like polio, adenovirus, or herpes) to control tumor progression.
Numerous companies are actively developing brain cancer therapies. With the FDA approval of OJEMDA, it now competes with Novartis' TAFINLAR-MEKINIST combination, approved last year for pediatric low-grade gliomas (pLGG) with BRAF V600 mutations. Leading pharmaceutical companies-including Genentech, Daiichi Sankyo, Bristol Myers Squibb, Bayer, Roche, AstraZeneca, Pfizer, and others-are advancing mid- and late-stage clinical trials for brain cancer treatments, positioning them for substantial market opportunities upon regulatory approval.
Scope of the Brain Cancer Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Brain Cancer Companies: Y-mAbs Therapeutics Inc., Shimadzu Corporation, Bristol-Myers Squibb, Bayer AG, AstraZeneca plc, Johnson & Johnson Inc., Merck & Co., Pfizer Inc., F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, and others
*
Key Brain Cancer Therapies: AVASTIN (bevacizumab), TEMODAR/TEMODAL, Vorasidenib, Paxalisib, and others
*
Brain Cancer Therapeutic Assessment: Brain Cancer current marketed and Brain Cancer emerging therapies
*
Brain Cancer Market Dynamics: Brain Cancer market drivers and Brain Cancer market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Brain Cancer Unmet Needs, KOL's views, Analyst's views, Brain Cancer Market Access and Reimbursement
To know more about Brain Cancer companies working in the treatment market, visit @ Brain Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/report-store/brain-cancer-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Contents
1. Brain Cancer Market Report Introduction
2. Executive Summary for Brain Cancer
3. SWOT analysis of Brain Cancer
4. Brain Cancer Patient Share (%) Overview at a Glance
5. Brain Cancer Market Overview at a Glance
6. Brain Cancer Disease Background and Overview
7. Brain Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Brain Cancer
9. Brain Cancer Current Treatment and Medical Practices
10. Brain Cancer Unmet Needs
11. Brain Cancer Emerging Therapies
12. Brain Cancer Market Outlook
13. Country-Wise Brain Cancer Market Analysis (2020-2034)
14. Brain Cancer Market Access and Reimbursement of Therapies
15. Brain Cancer Market Drivers
16. Brain Cancer Market Barriers
17. Brain Cancer Appendix
18. Brain Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Brain Cancer Pipeline
"Brain Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Brain Cancer market. A detailed picture of the Brain Cancer pipeline landscape is provided, which includes the disease overview and Brain Cancer treatment guidelines.
Brain Cancer Epidemiology
DelveInsight's 'Brain Cancer Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Brain Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=brain-cancer-market-report-2034-epidemiology-insights-pipeline-developments-and-key-regulatory-approvals-fda-ema-pmda-published-by-delveinsight-featuring-leading-companies-ymabs-therapeut]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brain Cancer Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring Leading Companies: Y-mAbs Therapeut here
News-ID: 4214629 • Views: …
More Releases from ABNewswire
Faster Anemia Recovery: When to Switch From Iron Pills to IV Iron
Iron deficiency anemia is exhausting. When your iron is low, everyday tasks feel heavier, your focus slips, and even simple workouts become harder. Oral iron supplements are usually the first step, but they don't always work fast enough-especially if your levels are very low or your body struggles to absorb iron.
That's where IV iron becomes a more efficient option. It delivers iron directly into your bloodstream, giving your body what…
Is Laser Hair Removal Safe for All Skin Tones? The Latest Technology Claims "Yes …
For years, laser hair removal was widely thought to be safest and most effective only for people with lighter skin and darker hair. That belief came from the limitations of early laser technology, which struggled to distinguish between pigment in the hair follicle and pigment in the skin. As a result, individuals with medium, dark, or very dark skin tones were often told they weren't good candidates.
Fortunately, the landscape has…
How Factoring Services Help Businesses with Late Payments
US customers pay their invoices late in over 50% of cases, causing cash flow disruptions, missed opportunities, and financial strain. Factoring services can fix these issues for you in almost no time. This financial solution converts unpaid invoices into immediate working capital in 24 hours.
If late payments are a constant challenge for your business, learn how you can take advantage of factoring to tackle it.
1. Get a steady cash flow
More…
Working with Different Balloon Types for Baby Showers: Latex, Foil, and Bubble B …
Selecting the right balloon type is one of the most practical yet impactful decisions when designing baby shower decor. Balloons form a major visual centerpiece, influencing not only how the event looks but also how long it lasts, how much it costs, and how easily it can be set up. So, let's have a look what are the best balloon types for your event and go deeper on their practical…
More Releases for Brain
Brain Training Apps Market Boosting the Brain: The Rise of Brain Training Apps a …
Brain Training Apps Market Assessment worth $ 44.43 Billion by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Training Apps Market- by App Type (Memory, Attention, Language, Executive Function, Visual/spatial, and Other App Types), User Type (Android, iOS and Other User Types), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031."
Get a free sample copy of…
Nutrient Survival Champions Brain Health During Alzheimer's & Brain Awareness Mo …
This June, Nutrient Survival is reminding people that nourishing your mind is as crucial as feeding your body, offering a revolutionary BrainCare® line.
Reno, NV (June 5, 2024) - As June marks Alzheimer's & Brain Awareness Month, Nutrient Survival, veteran-led pioneer in nutritional innovation, stands at the forefront of promoting
cognitive well-being with its revolutionary BrainCare® line and Brain Omega 3 Bar®. With alarming statistics highlighting the prevalence of brain-related ailments among…
Brain Monitoring Device Market - Harnessing the Power of Neurotechnology: Brain …
Newark, New Castle, USA: The "Brain Monitoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Brain Monitoring Device Market: https://www.growthplusreports.com/report/brain-monitoring-device-market/7889
This latest report researches the industry structure,…
Supercharge Your Brain: Revolutionary Brain Health Supplements for Improved Brai …
The global 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Brain Health Supplements industry. The current…
Global Wearable Brain Devices Market Growth by 2030 - Advanced Brain Monitoring …
The research report based on the Global Wearable Brain Devices Industry offers the detailed study of each and every aspect coupled with the Wearable Brain Devices market. The report also analyzes all the strategic developments made in the Wearable Brain Devices sector. The research report offers detailed and accurate numerical data on costs, revenues, sales, profits, etc. The market report narrowly analyzes all the key growth factors that are considered…
Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking.
Official Online Store - https://www.allnutritionhub.com/get-retro-x-focus-nootropic
How does the Retro X Focus Function?
It is common knowledge that we must work out…
